The stock of Annexon Inc (ANNX) has seen a 12.14% increase in the past week, with a 15.89% gain in the past month, and a 36.69% flourish in the past quarter. The volatility ratio for the week is 8.08%, and the volatility levels for the past 30 days are at 6.52% for ANNX. The simple moving average for the past 20 days is 13.04% for ANNX’s stock, with a 34.77% simple moving average for the past 200 days.
Is It Worth Investing in Annexon Inc (NASDAQ: ANNX) Right Now?
Moreover, the 36-month beta value for ANNX is 1.25. Analysts have varying opinions on the stock, with 6 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ANNX is 83.98M and currently, short sellers hold a 8.38% of that float. On September 19, 2024, ANNX’s average trading volume was 1.40M shares.
ANNX) stock’s latest price update
Annexon Inc (NASDAQ: ANNX)’s stock price has plunge by -0.86relation to previous closing price of 6.99. Nevertheless, the company has seen a 12.14% surge in its stock price over the last five trading sessions. seekingalpha.com reported 2024-08-17 that Annexon’s ANX005 shows promise for GBS. Phase 3 trial results indicate expedited recovery and durable benefits. ANNX targets the classical complement pathway, specifically the C1q protein, to address autoimmune, neurodegenerative, and ophthalmic conditions. The company’s pipeline includes ANX005, ANX007, and ANX1502. Due to its advanced development stage, ANX005 is the primary value driver.
Analysts’ Opinion of ANNX
Many brokerage firms have already submitted their reports for ANNX stocks, with JP Morgan repeating the rating for ANNX by listing it as a “Overweight.” The predicted price for ANNX in the upcoming period, according to JP Morgan is $11 based on the research report published on March 01, 2024 of the current year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see ANNX reach a price target of $6, previously predicting the price at $4. The rating they have provided for ANNX stocks is “Buy” according to the report published on December 21st, 2023.
Wells Fargo gave a rating of “Overweight” to ANNX, setting the target price at $11 in the report published on October 30th of the previous year.
ANNX Trading at 16.49% from the 50-Day Moving Average
After a stumble in the market that brought ANNX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.50% of loss for the given period.
Volatility was left at 6.52%, however, over the last 30 days, the volatility rate increased by 8.08%, as shares surge +15.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +37.23% upper at present.
During the last 5 trading sessions, ANNX rose by +12.14%, which changed the moving average for the period of 200-days by +178.31% in comparison to the 20-day moving average, which settled at $6.18. In addition, Annexon Inc saw 52.64% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ANNX starting from Yednock Ted, who sale 5,500 shares at the price of $6.16 back on Sep 12 ’24. After this action, Yednock Ted now owns 4,500 shares of Annexon Inc, valued at $33,880 using the latest closing price.
Yednock Ted, the Officer of Annexon Inc, proposed sale 5,500 shares at $6.16 during a trade that took place back on Sep 12 ’24, which means that Yednock Ted is holding shares at $33,880 based on the most recent closing price.
Stock Fundamentals for ANNX
Current profitability levels for the company are sitting at:
- -26.09 for the present operating margin
- 0.31 for the gross margin
The net margin for Annexon Inc stands at -23.67. The total capital return value is set at -0.33. Equity return is now at value -42.20, with -36.04 for asset returns.
Based on Annexon Inc (ANNX), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -3.37. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is -40.92.
Currently, EBITDA for the company is -140.46 million with net debt to EBITDA at 1.01. When we switch over and look at the enterprise to sales, we see a ratio of 124.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 21.81.
Conclusion
To wrap up, the performance of Annexon Inc (ANNX) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
